Literature DB >> 21307358

Evidence that a higher ATP cost of muscular contraction contributes to the lower mechanical efficiency associated with COPD: preliminary findings.

Gwenael Layec1, Luke J Haseler, Jan Hoff, Russell S Richardson.   

Abstract

Impaired metabolism in peripheral skeletal muscles potentially contributes to exercise intolerance in chronic obstructive pulmonary disease (COPD). We used (31)P-magnetic resonance spectroscopy ((31)P-MRS) to examine the energy cost and skeletal muscle energetics in six patients with COPD during dynamic plantar flexion exercise compared with six well-matched healthy control subjects. Patients with COPD displayed a higher energy cost of muscle contraction compared with the controls (control: 6.1 ± 3.1% of rest·min(-1)·W(-1), COPD: 13.6 ± 8.3% of rest·min(-1)·W(-1), P = 0.01). Although, the initial phosphocreatine resynthesis rate was also significantly attenuated in patients with COPD compared with controls (control: 74 ± 17% of rest/min, COPD: 52 ± 13% of rest/min, P = 0.04), when scaled to power output, oxidative ATP synthesis was similar between groups (6.5 ± 2.3% of rest·min(-1)·W(-1) in control and 7.8 ± 3.9% of rest·min(-1)·W(-1) in COPD, P = 0.52). Therefore, our results reveal, for the first time that in a small subset of patients with COPD a higher ATP cost of muscle contraction may substantially contribute to the lower mechanical efficiency previously reported in this population. In addition, it appears that some patients with COPD have preserved mitochondrial function and normal energy supply in lower limb skeletal muscle.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21307358      PMCID: PMC3293514          DOI: 10.1152/ajpregu.00835.2010

Source DB:  PubMed          Journal:  Am J Physiol Regul Integr Comp Physiol        ISSN: 0363-6119            Impact factor:   3.619


  34 in total

1.  Normalized metabolic stress for 31P-MR spectroscopy studies of human skeletal muscle: MVC vs. muscle volume.

Authors:  M D Fowler; T W Ryschon; R E Wysong; C A Combs; R S Balaban
Journal:  J Appl Physiol (1985)       Date:  1997-09

2.  Cytochrome oxidase activity and mitochondrial gene expression in skeletal muscle of patients with chronic obstructive pulmonary disease.

Authors:  J Sauleda; F García-Palmer; R J Wiesner; S Tarraga; I Harting; P Tomás; C Gómez; C Saus; A Palou; A G Agustí
Journal:  Am J Respir Crit Care Med       Date:  1998-05       Impact factor: 21.405

3.  Decreased mechanical efficiency in clinically stable patients with COPD.

Authors:  E M Baarends; A M Schols; M A Akkermans; E F Wouters
Journal:  Thorax       Date:  1997-11       Impact factor: 9.139

4.  In vivo assessment of mitochondrial functionality in human gastrocnemius muscle by 31P MRS. The role of pH in the evaluation of phosphocreatine and inorganic phosphate recoveries from exercise.

Authors:  S Iotti; R Lodi; C Frassineti; P Zaniol; B Barbiroli
Journal:  NMR Biomed       Date:  1993 Jul-Aug       Impact factor: 4.044

5.  Comparisons of ATP turnover in human muscle during ischemic and aerobic exercise using 31P magnetic resonance spectroscopy.

Authors:  G J Kemp; C H Thompson; P R Barnes; G K Radda
Journal:  Magn Reson Med       Date:  1994-03       Impact factor: 4.668

6.  Skeletal muscle metabolism during exercise and recovery in patients with respiratory failure.

Authors:  C H Thompson; R J Davies; G J Kemp; D J Taylor; G K Radda; B Rajagopalan
Journal:  Thorax       Date:  1993-05       Impact factor: 9.139

7.  Oxidative capacity of the skeletal muscle and lactic acid kinetics during exercise in normal subjects and in patients with COPD.

Authors:  F Maltais; A A Simard; C Simard; J Jobin; P Desgagnés; P LeBlanc
Journal:  Am J Respir Crit Care Med       Date:  1996-01       Impact factor: 21.405

8.  Metabolic enzyme activity in the quadriceps femoris muscle in patients with severe chronic obstructive pulmonary disease.

Authors:  P Jakobsson; L Jorfeldt; J Henriksson
Journal:  Am J Respir Crit Care Med       Date:  1995-02       Impact factor: 21.405

9.  Regulation of oxygen consumption in fast- and slow-twitch muscle.

Authors:  M J Kushmerick; R A Meyer; T R Brown
Journal:  Am J Physiol       Date:  1992-09

10.  Exercise capacity and ventilatory, circulatory, and symptom limitation in patients with chronic airflow limitation.

Authors:  K J Killian; P Leblanc; D H Martin; E Summers; N L Jones; E J Campbell
Journal:  Am Rev Respir Dis       Date:  1992-10
View more
  15 in total

1.  Quadriceps exercise intolerance in patients with chronic obstructive pulmonary disease: the potential role of altered skeletal muscle mitochondrial respiration.

Authors:  Jayson R Gifford; Joel D Trinity; Gwenael Layec; Ryan S Garten; Song-Young Park; Matthew J Rossman; Steen Larsen; Flemming Dela; Russell S Richardson
Journal:  J Appl Physiol (1985)       Date:  2015-08-13

2.  Passive leg movement in chronic obstructive pulmonary disease: evidence of locomotor muscle vascular dysfunction.

Authors:  Stephen J Ives; Gwenael Layec; Corey R Hart; Joel D Trinity; Jayson R Gifford; Ryan S Garten; Melissa A H Witman; Jacob R Sorensen; Russell S Richardson
Journal:  J Appl Physiol (1985)       Date:  2020-04-23

3.  High oxygen extraction and slow recovery of muscle deoxygenation kinetics after neuromuscular electrical stimulation in COPD patients.

Authors:  Diego de Paiva Azevedo; Wladimir Musetti Medeiros; Flávia Fernandes Manfredi de Freitas; Cesar Ferreira Amorim; Ana Cristina Oliveira Gimenes; Jose Alberto Neder; Luciana Dias Chiavegato
Journal:  Eur J Appl Physiol       Date:  2016-07-28       Impact factor: 3.078

4.  Determinants of the diminished exercise capacity in patients with chronic obstructive pulmonary disease: looking beyond the lungs.

Authors:  Ryan M Broxterman; Jan Hoff; Peter D Wagner; Russell S Richardson
Journal:  J Physiol       Date:  2020-01-19       Impact factor: 5.182

Review 5.  An official American Thoracic Society/European Respiratory Society statement: update on limb muscle dysfunction in chronic obstructive pulmonary disease.

Authors:  François Maltais; Marc Decramer; Richard Casaburi; Esther Barreiro; Yan Burelle; Richard Debigaré; P N Richard Dekhuijzen; Frits Franssen; Ghislaine Gayan-Ramirez; Joaquim Gea; Harry R Gosker; Rik Gosselink; Maurice Hayot; Sabah N A Hussain; Wim Janssens; Micheal I Polkey; Josep Roca; Didier Saey; Annemie M W J Schols; Martijn A Spruit; Michael Steiner; Tanja Taivassalo; Thierry Troosters; Ioannis Vogiatzis; Peter D Wagner
Journal:  Am J Respir Crit Care Med       Date:  2014-05-01       Impact factor: 21.405

6.  Oxygen delivery and the restoration of the muscle energetic balance following exercise: implications for delayed muscle recovery in patients with COPD.

Authors:  Gwenael Layec; Corey R Hart; Joel D Trinity; Oh-Sung Kwon; Matthew J Rossman; Ryan M Broxterman; Yann Le Fur; Eun-Kee Jeong; Russell S Richardson
Journal:  Am J Physiol Endocrinol Metab       Date:  2017-03-14       Impact factor: 4.310

7.  Altered skeletal muscle mitochondrial phenotype in COPD: disease vs. disuse.

Authors:  Jayson R Gifford; Joel D Trinity; Oh-Sung Kwon; Gwenael Layec; Ryan S Garten; Song-Young Park; Ashley D Nelson; Russell S Richardson
Journal:  J Appl Physiol (1985)       Date:  2017-12-28

8.  The effect of higher ATP cost of contraction on the metabolic response to graded exercise in patients with chronic obstructive pulmonary disease.

Authors:  Gwenael Layec; Luke J Haseler; Russell S Richardson
Journal:  J Appl Physiol (1985)       Date:  2011-12-15

9.  Mechanical efficiency of high versus moderate intensity aerobic exercise in coronary heart disease patients: A randomized clinical trial.

Authors:  Koldobika Villelabeitia-Jaureguizar; Davinia Vicente-Campos; Alejandro Berenguel Senen; Verónica Hernández Jiménez; Lorena Ruiz Bautista; María Elvira Barrios Garrido-Lestache; Jose López Chicharro
Journal:  Cardiol J       Date:  2018-05-10       Impact factor: 2.737

10.  Severe loss of mechanical efficiency in COVID-19 patients.

Authors:  Eulogio Pleguezuelos; Amin Del Carmen; Gemma Llorensi; Jessica Carcole; Paula Casarramona; Eva Moreno; Pilar Ortega; Mateo Serra-Prat; Elisabet Palomera; Marc M Miravitlles; Joan Carles Yebenes; Ramón Boixeda; Lluis Campins; Koldo Villelabeitia-Jaureguizar; Manuel Vicente Garnacho-Castaño
Journal:  J Cachexia Sarcopenia Muscle       Date:  2021-06-08       Impact factor: 12.063

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.